Nobivac Feline 1-HCPCh+FeLV

Nobivac Feline 1-HCPCh+FeLV Cat and Kitten Vaccine

(MLV & Chlamydia & KV) Feline Leukemia, Rhinotracheitis, Calicivirus, Panleukopenia, Chlamydia Psittaci

Nobivac? Feline 1-HCPCh+FeLV is a combination vaccine offering protection against feline rhinotracheitis, calici, panleukopenia, feline leukemia viruses, and Chlamydia psittaci. Effective for cats 9 weeks and older, it ensures at least 2 years of immunity against feline leukemia.

Key Benefits

• Protects against core feline diseases, including feline rhinotracheitis, calici, panleukopenia, feline leukemia viruses, and Chlamydia psittaci
• Only Nobivac? FeLV vaccines are labeled to be effective against persistent viremia in cats exposed to virulent leukemia virus.
• Only USDA-licensed FeLV vaccine with 2-Year Duration of Immunity (DOI)
• Ideal for indoor, outdoor, and frequently boarded cats
• 99% reaction-free safety profile from millions of doses

Administration

Administer subcutaneously or intramuscularly. Initial 1 mL dose at 9 weeks of age, followed by a second 1 mL dose 3-4 weeks later. Consult a veterinarian for revaccination needs.

Does NOT include needles or syringes.